Krebs Biochemicals Closes Trading Window for Q2 FY27 Results

Krebs Biochemicals & Industries Ltd has announced the closure of its trading window for the quarter ending September 30, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut for promoters, directors, designated persons, and their immediate relatives from the close of business hours on September 30, 2026, until 48 hours after the declaration of the Unaudited Financial Results for the second quarter and half-year ended September 30, 2026. The company will inform the stock exchanges about the date of the board meeting to consider these results in due course.